NCT06583291View on ClinicalTrials.gov

iDAP Injection in the Treatment of Parkinson's Disease

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

October 1, 2024

Primary Completion Date

October 1, 2028

Study Completion Date

October 1, 2028

Conditions

Parkinson Disease

Interventions

DRUG

Allogeneic dopaminergic neural precursor cell(iDAP)

Bilateral implantation

All Listed Sponsors

lead

Anhui Provincial Hospital

OTHER_GOV